OKLAHOMA CITY — Oklahomans will have access to the newest, cutting-edge therapies, thanks to the Stephenson Cancer Center’s designation as a Lead Academic Site by the National Cancer Institute in its new National Clinical Trials Network.
Lead Academic Sites form the centerpiece of the National Cancer Institute’s new strategy to conduct high-impact clinical trials and deliver new therapies to cancer patients.
The Stephenson Cancer Center at the University of Oklahoma Health Sciences Center is one of only 30 Lead Academic Sites nationwide to be selected as a primary location for conducting this high-impact clinical research.
Lead Academic Site designation is awarded through a federal research grant that will bring more than $6 million in funding to Oklahoma over the next five years.
The designation establishes the Stephenson as a national center of excellence in conducting innovative clinical trials research.
“This new grant is a recognition that the Stephenson Cancer Center is taking its place among the leading cancer centers in the nation,” OU President David L. Boren said.
The Stephenson Cancer Center was selected as a Lead Academic Site through a highly competitive process evaluating the Stephenson’s scientific contributions at a national level, along with its ability to conduct high-quality clinical trials research.
Robert Mannel, MD, Stephenson Cancer Center director, serves as principal investigator for the grant. Scott McMeekin, MD, deputy director for clinical research, serves as the grant’s co-principal investigator.
Key collaborators in this effort include the State of Oklahoma, which established the Stephenson Cancer Center in 2001, and the Oklahoma Tobacco Settlement Endowment Trust, which provides major support for innovative cancer research being conducted at the Stephenson. Others include Oklahoma’s philanthropic and corporate communities.
Breaking news, severe weather alerts, AMBER alerts, sports scores from The Norman Transcript are available as text messages right to your phone or mobile device. You decide which type of alerts you want to receive. Find out more or to signup, click here.